ITRACONAZOLE

Itraconazole was first approved by the U.S. Food and Drug Administration (FDA) on June 30, 1992.

Itraconazole treats various fungal infections, including those affecting the skin, nails, and mucous membranes. It is also effective against certain systemic fungal infections caused by susceptible organisms. Additionally, this medication is commonly prescribed for onychomycosis, a fungal nail infection.

Itraconazole is available in oral capsules. Your healthcare provider will determine the dosage of this medication based on your medical condition, and it is crucial to adhere to their prescribed form and dosage for safe and effective treatment.

Common side effects may include gastrointestinal disturbances like nausea and stomach pain, headaches, dizziness, and skin rashes. In some cases, individuals may experience muscle or joint pain, changes in taste sensation (dysgeusia), and fatigue. Serious side effects can include liver toxicity and rare allergic reactions that may lead to difficulty breathing or swelling of the face, lips, tongue, or throat. Seek medical attention immediately if any severe or unusual side effects occur.

Itraconazole use requires caution, especially in individuals with liver conditions, as it may cause toxicity. The medication is contraindicated in patients with known hypersensitivity to Itraconazole or its components. It should not be used during pregnancy and is generally not recommended during breastfeeding. Tendon disorders have been reported. Elderly patients may be more susceptible to certain side effects,

Regular liver function monitoring is essential during treatment. Itraconazole may interact with various medications, so inform your healthcare provider about all drugs you are taking to avoid potential interactions. Patients with a history of heart rhythm disorders should be closely monitored, as this medication may prolong the QT interval. Elderly people require close monitoring and potential dosage adjustments. Always communicate concerns with your healthcare provider to ensure safe and effective use of Itraconazole.

Regular monitoring of liver function is essential, particularly in patients with pre-existing liver disease or a history of hepatic impairment, as itraconazole can cause hepatotoxicity. If signs of allergic reaction occur, such as difficulty breathing or swelling, seek immediate medical care. Itraconazole may prolong the QT interval, which can lead to cardiac arrhythmias; patients with a history of heart rhythm disorders require careful monitoring. In pregnancy and during breastfeeding, consultation with a healthcare provider is necessary before use due to potential risks to the foetus or nursing infant. Close monitoring is required in paediatric and geriatric populations. By following these precautions and discussing any concerns with your healthcare provider, safe and effective treatment with this medication can be achieved.

KD Tripathi, Antifungal Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 838-848. Harry W. Lampiris, Daniel S. Maddix, Antifungal Agents, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 853-862. S.H. Ibbotson, R.S. Dawe, Skin Disease, Davidson’s Principles and Practice of Medicine, 22nd Edition, 2014, 1249-1305. Sanico N.V., FDA (Food and Drug Safety Administration) [Revised on April 2001] [Accessed on 26th Jul 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022484s000lbl.pdf